Comparing Safety and Efficacy of "Third-Generation" Antiepileptic Drugs: Long-Term Extension and Post-marketing Treatment.

about

A New Chemoenzymatic Synthesis of the Chiral Key Intermediate of the Antiepileptic Brivaracetam

P2860

Q58696632-D11E256B-623D-401F-89F1-7D4A00E5AAB0

P2860

Comparing Safety and Efficacy of "Third-Generation" Antiepileptic Drugs: Long-Term Extension and Post-marketing Treatment.

Item

http://www.wikidata.org/entity/Q50075643

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Comparing Safety and Efficacy ...... and Post-marketing Treatment.

@en

Comparing Safety and Efficacy ...... and Post-marketing Treatment.

@nl

type

Item

label

Comparing Safety and Efficacy ...... and Post-marketing Treatment.

@en

Comparing Safety and Efficacy ...... and Post-marketing Treatment.

@nl

prefLabel

Comparing Safety and Efficacy ...... and Post-marketing Treatment.

@en

Comparing Safety and Efficacy ...... and Post-marketing Treatment.

@nl

P1476

Comparing Safety and Efficacy ...... n and Post-marketing Treatment

@en

P2093

Charlotte S Kwok

http://www.w3.org/2001/XMLSchema#string

Gregory L Krauss

http://www.w3.org/2001/XMLSchema#string

P2860

Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304

Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.

A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures.

A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.

Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: integrated analysis of pooled data from double-blind phase III clinical studies.

Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures.

Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307.

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial.

Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study.

Severe persistent visual field constriction associated with vigabatrin

P2888

s40263-017-0480-6

P304

959-974

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S40263-017-0480-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Emily L Johnson

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29204953

http://www.w3.org/2001/XMLSchema#string

Comparing Safety and Efficacy of "Third-Generation" Antiepileptic Drugs: Long-Term Extension and Post-marketing Treatment.

about

P2860

P2860

Comparing Safety and Efficacy of "Third-Generation" Antiepileptic Drugs: Long-Term Extension and Post-marketing Treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698